Sven deVos

871 total citations
6 papers, 451 citations indexed

About

Sven deVos is a scholar working on Pathology and Forensic Medicine, Oncology and Immunology. According to data from OpenAlex, Sven deVos has authored 6 papers receiving a total of 451 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Pathology and Forensic Medicine, 3 papers in Oncology and 2 papers in Immunology. Recurrent topics in Sven deVos's work include Lymphoma Diagnosis and Treatment (2 papers), T-cell and Retrovirus Studies (1 paper) and Tuberculosis Research and Epidemiology (1 paper). Sven deVos is often cited by papers focused on Lymphoma Diagnosis and Treatment (2 papers), T-cell and Retrovirus Studies (1 paper) and Tuberculosis Research and Epidemiology (1 paper). Sven deVos collaborates with scholars based in United States, Germany and France. Sven deVos's co-authors include H. Phillip Koeffler, Bülent Sargin, Lara Tickenbrock, Hubert Serve, Matthias Stelljes, Gabriele Köhler, Martin Ruthardt, Ping Ji, Carsten Müller‐Tidow and Björn Steffen and has published in prestigious journals such as Blood, Molecular and Cellular Biology and International Journal of Cancer.

In The Last Decade

Sven deVos

6 papers receiving 440 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sven deVos United States	6	255	153	143	114	65	6	451
Anna Ferrari Italy	12	272 1.1×	117 0.8×	55 0.4×	129 1.1×	53 0.8×	48	511
А. В. Самцов Russia	7	291 1.1×	138 0.9×	218 1.5×	50 0.4×	201 3.1×	39	652
Luciana Impera Italy	14	227 0.9×	66 0.4×	63 0.4×	201 1.8×	33 0.5×	37	490
Bhumi Patel United States	7	150 0.6×	78 0.5×	36 0.3×	105 0.9×	80 1.2×	9	378
Soji Kurita Japan	10	112 0.4×	225 1.5×	231 1.6×	34 0.3×	126 1.9×	14	447
Chikashi Yoshida Japan	15	153 0.6×	92 0.6×	65 0.5×	346 3.0×	97 1.5×	45	600
Deborah Ruggeri Italy	8	172 0.7×	53 0.3×	46 0.3×	281 2.5×	41 0.6×	9	378
Virginia Giuliani Italy	3	315 1.2×	149 1.0×	42 0.3×	92 0.8×	118 1.8×	4	423
Sebastian Ginzel Germany	11	77 0.3×	85 0.6×	50 0.3×	61 0.5×	186 2.9×	16	331
Agata Cieślak France	12	173 0.7×	110 0.7×	105 0.7×	184 1.6×	92 1.4×	16	492

Countries citing papers authored by Sven deVos

Since Specialization

Citations

This map shows the geographic impact of Sven deVos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sven deVos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sven deVos more than expected).

Fields of papers citing papers by Sven deVos

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sven deVos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sven deVos. The network helps show where Sven deVos may publish in the future.

Co-authorship network of co-authors of Sven deVos

This figure shows the co-authorship network connecting the top 25 collaborators of Sven deVos. A scholar is included among the top collaborators of Sven deVos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sven deVos. Sven deVos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Wagner‐Johnston, Nina D., Stephen J. Schuster, Sven deVos, et al.. (2020). Outcomes of patients with up to 6 years of follow-up from a phase 2 study of idelalisib for relapsed indolent lymphomas. Leukemia & lymphoma. 62(5). 1077–1087. 12 indexed citations

2.

Sehn, Laurie H., Michael Hallek, Wojciech Jurczak, et al.. (2016). A Retrospective Analysis of Pneumocystis Jirovecii Pneumonia Infection in Patients Receiving Idelalisib in Clinical Trials. Blood. 128(22). 3705–3705. 21 indexed citations

3.

Hsi, Eric D., Sin‐Ho Jung, Raymond Lai, et al.. (2008). Ki67 and PIM1 expression predict outcome in mantle cell lymphoma treated with high dose therapy, stem cell transplantation and rituximab: a Cancer and Leukemia Group B 59909 correlative science study. Leukemia & lymphoma. 49(11). 2081–2090. 87 indexed citations

4.

Tsukasaki, Kunihiro, Sakae Tanosaki, Sven deVos, et al.. (2004). Identifying progression‐associated genes in adult T‐cell leukemia/lymphoma by using oligonucleotide microarrays. International Journal of Cancer. 109(6). 875–881. 31 indexed citations

5.

Müller‐Tidow, Carsten, Björn Steffen, Thomas Cauvet, et al.. (2004). Translocation Products in Acute Myeloid Leukemia Activate the Wnt Signaling Pathway in Hematopoietic Cells. Molecular and Cellular Biology. 24(7). 2890–2904. 243 indexed citations

6.

Said, Jonathan W., I. Peter Shintaku, Hiroya Asou, et al.. (1999). Herpesvirus 8 Inclusions in Primary Effusion Lymphoma. Archives of Pathology & Laboratory Medicine. 123(3). 257–260. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact